NYSE:PFEPharmaceuticals
The Bull Case for Pfizer (PFE) Could Change Following Major Patent Litigation Developments
Earlier this month, Pfizer Inc. was involved in two significant legal developments: the certification of settlement classes over alleged price-fixing in the generic drug market, and a key claim construction ruling in a high-profile patent infringement lawsuit relating to its COVID-19 mRNA vaccine technology.
These legal proceedings may influence Pfizer’s future liabilities and highlight the complexity of intellectual property rights and regulatory compliance for large pharmaceutical...